Compare MasTec Inc (MTZ) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasTec Inc vs Nuvalent Inc — how do they compare? MasTec Inc trades at $350.55 (market cap $26.60B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: MasTec Inc is far larger — about 2.7× Nuvalent Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, MasTec Inc nearer its low. Which is the better fit depends on your goals.
| MTZ | NUVL | |
|---|---|---|
Market Cap | $26.60B | $9.81B |
Sector | Technology | Technology |
52-Week High | $437.51 | $123.96 |
52-Week Low | $172.51 | $72.16 |
Enterprise Value | $29.34B | $8.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
